Activation_NN
of_IN
protein_NN
kinase_NN
C_NN
and_CC
elevation_NN
of_IN
cAMP_NN
interact_VBP
synergistically_RB
to_TO
raise_VB
c-Fos_NN
and_CC
AP-1_NN
activity_NN
in_IN
Jurkat_NN
cells_NNS
._.

We_PRP
have_VBP
earlier_RBR
found_VBN
that_IN
in_IN
Jurkat_NN
cells_NNS
activation_NN
of_IN
protein_NN
kinase_NN
C_NN
-LRB-_-LRB-
PKC_NN
-RRB-_-RRB-
enhances_VBZ
the_DT
cyclic_JJ
adenosine_NN
monophosphate_NN
-LRB-_-LRB-
cAMP_NN
-RRB-_-RRB-
accumulation_NN
induced_VBN
by_IN
adenosine_NN
receptor_NN
stimulation_NN
or_CC
activation_NN
of_IN
Gs_NN
._.

Here_RB
we_PRP
have_VBP
therefore_RB
examined_VBN
the_DT
effect_NN
of_IN
the_DT
phorbol_NN
ester_NN
PMA_NN
-LRB-_-LRB-
phorbol_NN
12-myristate_NN
13-acetate_NN
-RRB-_-RRB-
which_WDT
stimulates_VBZ
PKC_NN
and_CC
a_DT
combination_NN
of_IN
the_DT
adenosine_NN
receptor_NN
agonist_NN
NECA_NN
-LRB-_-LRB-
5_CD
'_NN
-_:
-LRB-_-LRB-
N-ethyl_NN
-RRB-_-RRB-
-_:
carboxamido_JJ
adenosine_NN
-RRB-_-RRB-
and_CC
forskolin_NN
to_TO
raise_VB
cAMP_NN
,_,
on_IN
the_DT
levels_NNS
of_IN
c-Fos_NN
and_CC
Jun_NN
and_CC
on_IN
the_DT
binding_NN
and_CC
transcriptional_JJ
activity_NN
of_IN
the_DT
transcription_NN
factor_NN
,_,
activator_NN
protein-1_NN
-LRB-_-LRB-
AP-1_NN
-RRB-_-RRB-
._.

PMA_NN
treatment_NN
caused_VBD
a_DT
concentration_NN
-_:
and_CC
time-dependent_JJ
increase_NN
in_IN
both_CC
c-Fos_NN
and_CC
Jun_NN
immunoreactivity_NN
in_IN
contrast_NN
to_TO
cAMP_NN
elevation_NN
that_WDT
had_VBD
only_RB
a_DT
slight_JJ
effect_NN
._.

Both_CC
PMA_NN
and_CC
the_DT
combination_NN
of_IN
NECA_NN
and_CC
forskolin_NN
acted_VBD
together_RB
either_CC
to_TO
increase_NN
-LRB-_-LRB-
c-Fos_NN
-RRB-_-RRB-
or_CC
decrease_NN
-LRB-_-LRB-
Jun_NN
-RRB-_-RRB-
protein_NN
levels_NNS
as_RB
well_RB
as_IN
increasing_VBG
AP-1_NN
binding_NN
,_,
as_IN
judged_VBN
by_IN
gel-shift_JJ
assay_NN
,_,
and_CC
AP-1_NN
transcriptional_JJ
activity_NN
._.

Furthermore_RB
there_EX
was_VBD
a_DT
clear-cut_JJ
synergy_NN
between_IN
the_DT
PKC_NN
stimulator_NN
and_CC
the_DT
cAMP_NN
elevating_NN
agents_NNS
._.

The_DT
results_NNS
demonstrate_VBP
that_IN
the_DT
simultaneous_JJ
activation_NN
of_IN
PKC_NN
and_CC
elevation_NN
of_IN
cAMP_NN
leads_VBZ
to_TO
an_DT
enhanced_VBN
AP-1_NN
transcriptional_JJ
activity_NN
in_IN
a_DT
T-leukemia_NN
cell_NN
line_NN
,_,
suggesting_VBG
that_IN
the_DT
previously_RB
observed_VBN
interaction_NN
between_IN
the_DT
parallel_JJ
signal_NN
transduction_NN
pathways_NNS
may_MD
have_VB
functional_JJ
consequences_NNS
at_IN
the_DT
level_NN
of_IN
gene_NN
transcription_NN
._.

